000 | 01194 a2200301 4500 | ||
---|---|---|---|
005 | 20250518073326.0 | ||
264 | 0 | _c20200805 | |
008 | 202008s 0 0 eng d | ||
022 | _a1520-4383 | ||
024 | 7 |
_a10.1182/hematology.2019000048 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGerds, Aaron T | |
245 | 0 | 0 |
_aBeyond JAK-STAT: novel therapeutic targets in Ph-negative MPN. _h[electronic resource] |
260 |
_bHematology. American Society of Hematology. Education Program _c12 2019 |
||
300 |
_a407-414 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJanus Kinases _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPolycythemia Vera _xdrug therapy |
650 | 0 | 4 |
_aPrimary Myelofibrosis _xdrug therapy |
650 | 0 | 4 |
_aSTAT Transcription Factors _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aThrombocythemia, Essential _xdrug therapy |
773 | 0 |
_tHematology. American Society of Hematology. Education Program _gvol. 2019 _gno. 1 _gp. 407-414 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/hematology.2019000048 _zAvailable from publisher's website |
999 |
_c30392865 _d30392865 |